Based on Medical Statistical Analysis and Screening (Dispensary) Examination, Identification of the Most Common Somatic and Congenital Diseases in Children, With the Further Development of More Effective Methods of Treatment and Recovery

What this Trial Is About

This research aims to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, focusing on frequently ill children up to age 15. It investigates common congenital diseases, bronchopulmonary and cardiovascular conditions, and evaluates current treatment methods to develop improved therapies and rehabilitation approaches. The study is an early phase 1 clinical trial sponsored by Tashkent State Medical University. The study includes several stages: initially identifying commonly encountered diseases through clinical and laboratory examinations; then assessing effectiveness of standard treatments; followed by developing and applying new treatment tactics approved by an ethics committee. During the rehabilitation phase, microelements and vitamins may be added alongside physiotherapy. The final stage involves creating clinical recommendations for doctors based on research findings. Participants will undergo thorough assessments including medical history collection, physical exams, consultations with specialists, and various laboratory and instrumental tests such as blood and urine analyses, X-rays, ultrasounds, and immunological studies. Quality of life will be evaluated using standardized questionnaires. The study involves long-term monitoring over several years, working with archival data, patient grouping for immunity studies, and clinical trial evaluations to measure outcomes and safety.

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children